Document is current
Any future updates will be listed below
-
Authors
Mitsuyuki, Satoshi https://orcid.org/0000-0002-0059-5038
Shimomura, Yoshimitsu https://orcid.org/0000-0003-1018-9508
Mizumaki, Hiroki https://orcid.org/0000-0002-9933-4638
Yanada, Masamitsu https://orcid.org/0000-0003-1602-9775
Mizuno, Shohei https://orcid.org/0000-0002-4405-8808
Uchida, Naoyuki https://orcid.org/0000-0001-5952-5926
Doki, Noriko https://orcid.org/0000-0002-8661-3179
Ito, Ayumu https://orcid.org/0000-0001-5681-6357
Tanaka, Masatsugu
Nishida, Tetsuya
Katayama, Yuta https://orcid.org/0000-0001-5054-9104
Yoshihara, Satoshi https://orcid.org/0000-0002-8537-2422
Eto, Tetsuya
Takada, Satoru
Ota, Shuichi https://orcid.org/0000-0002-3631-244X
Toyosaki, Masako
Hasegawa, Yuta
Nakamae, Hirohisa https://orcid.org/0000-0003-4203-990X
Kawamura, Koji
Onizuka, Makoto https://orcid.org/0000-0003-3864-0823
Fukuda, Takahiro
Ohbiki, Marie https://orcid.org/0009-0007-3522-2278
Atsuta, Yoshiko https://orcid.org/0000-0003-4404-2870
Konuma, Takaaki https://orcid.org/0000-0002-1953-8463
- License Information
-
More Information
Article History
Received: 22 September 2024
Revised: 20 November 2024
Accepted: 3 December 2024
First Online: 10 December 2024
Ethics approval and consent to participate
: This study was approved by the Japanese Data Center for Hematopoietic Cell Transplantation and the Institutional Review Board of Kobe City Medical Center General Hospital and conducted in accordance with the Declaration of Helsinki (approval number: zn240506). Written informed consent was obtained from each patient at each institution before Transplant Registry Unified Management Program 2 registration.
: Shohei Mizuno received research funding from Hayashikane Sangyo and lecture fees from Janssen Pharmaceutical. The other authors declare no conflicts of interest associated with this manuscript.
